A phase 1/2 randomized study of IGM-2323 in relapsed/refractory Non-Hodgkin Lymphomas.

Loretta Nastoupil; Elizabeth Budde; Won Seog Kim; Ajay K. Gopal; Chan Cheah; Ian Flinn; Gareth P. Gregory; Matthew Matasar; Catherine S. Diefenbach; Matthew Ku; Sung-Soo Yoon; Ibrahim Qazi; Rachel Wei; Maya Leabman; Genevive Hernandez; Iris Sison; Bruce Keyt; Thomas Manley; Philippe Armand

doi:10.1158/1538-7445.AM2022-CT125

A phase 1/2 randomized study of IGM-2323 in relapsed/refractory Non-Hodgkin Lymphomas.

Loretta Nastoupil, Elizabeth Budde, Won Seog Kim, Ajay K. Gopal, Chan Cheah, Ian Flinn, Gareth P. Gregory, Matthew Matasar, Catherine S. Diefenbach, Matthew Ku, Sung-Soo Yoon, Ibrahim Qazi, Rachel Wei, Maya Leabman, Genevive Hernandez, Iris Sison, Bruce Keyt, Thomas Manley, Philippe Armand

Medicine Monash Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	CT125
Number of pages	1
Journal	Cancer Research
Volume	82
Issue number	12 Suppl
DOIs	https://doi.org/10.1158/1538-7445.AM2022-CT125
Publication status	Published - 15 Jun 2022
Event	AACR Annual Meeting 2022 - Ernest N. Morial Convention Center, Louisiana, United States of America Duration: 8 Apr 2022 → 13 Apr 2022 https://aacrjournals.org/cancerres/issue/82/12_Supplement

Access to Document

10.1158/1538-7445.AM2022-CT125Licence: Unspecified

Cite this

Nastoupil, L., Budde, E., Kim, W. S., Gopal, A. K., Cheah, C., Flinn, I., Gregory, G. P., Matasar, M., Diefenbach, C. S., Ku, M., Yoon, S.-S., Qazi, I., Wei, R., Leabman, M., Hernandez, G., Sison, I., Keyt, B., Manley, T., & Armand, P. (2022). A phase 1/2 randomized study of IGM-2323 in relapsed/refractory Non-Hodgkin Lymphomas. Cancer Research, 82(12 Suppl), Article CT125. https://doi.org/10.1158/1538-7445.AM2022-CT125

@article{785f972a6a9f4c078a2486d173b17094,

title = "A phase 1/2 randomized study of IGM-2323 in relapsed/refractory Non-Hodgkin Lymphomas.",

author = "Loretta Nastoupil and Elizabeth Budde and Kim, {Won Seog} and Gopal, {Ajay K.} and Chan Cheah and Ian Flinn and Gregory, {Gareth P.} and Matthew Matasar and Diefenbach, {Catherine S.} and Matthew Ku and Sung-Soo Yoon and Ibrahim Qazi and Rachel Wei and Maya Leabman and Genevive Hernandez and Iris Sison and Bruce Keyt and Thomas Manley and Philippe Armand",

note = "POSTER PRESENTATIONS - PROFFERED ABSTRACTS| JUNE 15 2022; AACR Annual Meeting 2022 ; Conference date: 08-04-2022 Through 13-04-2022",

year = "2022",

month = jun,

day = "15",

doi = "10.1158/1538-7445.AM2022-CT125",

language = "English",

volume = "82",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research (AACR)",

number = "12 Suppl",

url = "https://aacrjournals.org/cancerres/issue/82/12_Supplement",

}

Nastoupil, L, Budde, E, Kim, WS, Gopal, AK, Cheah, C, Flinn, I, Gregory, GP, Matasar, M, Diefenbach, CS, Ku, M, Yoon, S-S, Qazi, I, Wei, R, Leabman, M, Hernandez, G, Sison, I, Keyt, B, Manley, T & Armand, P 2022, 'A phase 1/2 randomized study of IGM-2323 in relapsed/refractory Non-Hodgkin Lymphomas.', Cancer Research, vol. 82, no. 12 Suppl, CT125. https://doi.org/10.1158/1538-7445.AM2022-CT125

TY - JOUR

T1 - A phase 1/2 randomized study of IGM-2323 in relapsed/refractory Non-Hodgkin Lymphomas.

AU - Nastoupil, Loretta

AU - Budde, Elizabeth

AU - Kim, Won Seog

AU - Gopal, Ajay K.

AU - Cheah, Chan

AU - Flinn, Ian

AU - Gregory, Gareth P.

AU - Matasar, Matthew

AU - Diefenbach, Catherine S.

AU - Ku, Matthew

AU - Yoon, Sung-Soo

AU - Qazi, Ibrahim

AU - Wei, Rachel

AU - Leabman, Maya

AU - Hernandez, Genevive

AU - Sison, Iris

AU - Keyt, Bruce

AU - Manley, Thomas

AU - Armand, Philippe

N1 - POSTER PRESENTATIONS - PROFFERED ABSTRACTS| JUNE 15 2022

PY - 2022/6/15

Y1 - 2022/6/15

U2 - 10.1158/1538-7445.AM2022-CT125

DO - 10.1158/1538-7445.AM2022-CT125

M3 - Meeting Abstract

SN - 0008-5472

VL - 82

JO - Cancer Research

JF - Cancer Research

IS - 12 Suppl

M1 - CT125

T2 - AACR Annual Meeting 2022

Y2 - 8 April 2022 through 13 April 2022

ER -